Filtern
Quelle
  • ariva.de
  • fool.de
  • ntg24.de
  • wallstreet-online.de
Markt
  • Amerika
  • Asien
  • Australien
  • Europa
Index
  • DAX
  • MDAX
  • NASDAQ
  • NYSE
  • SDAX
  • TecDAX
Anlageklasse
  • Aktien
  • Anleihen
  • CFD
  • Derivate
  • ETF
  • Fonds
  • Rohstoffe
  • Währungen
Nachrichtentyp
  • Ad-hoc Mitteilungen
  • Analysen
  • Chartanalysen
  • Empfehlungen
  • IPO Nachrichten
  • Marktberichte
  • Nachrichten
Thema
  • Biotechnologie
  • Finanzdienstleistungen
  • Immobilien
  • Internet
  • Lifestyle
  • Nanotechnologie
  • Politik
  • Recht
  • Sonstige Technologie
  • Sonstiges
  • Sport
  • Steuern
  • Telekommunikation
  • Termine
  • Unternehmen
  • Wissenswertes
Filter zurücksetzen

Nachrichten Seite 3.280

30. Mai 2026 16:00 Neutral
Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ MOLN), a clinical-stage biotech company …
Quelle: ariva.de
30. Mai 2026 16:00 Neutral
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved anti-tumor activity in platinum-resistant ovarian cancer and in uterine cancer with a 63% …
Quelle: ariva.de
30. Mai 2026 16:00 Positiv
Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced detailed efficacy and safety results from RINGSIDE, the global, randomized, double-blind, placebo-controlled …
Quelle: wallstreet-online.de
30. Mai 2026 16:00 Neutral
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced results from the ENZAMET trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the Decipher Prostate …
Quelle: wallstreet-online.de
30. Mai 2026 16:00 Positiv
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi/Minjuvi) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi/Minjuvi), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide …
Quelle: wallstreet-online.de
30. Mai 2026 16:00 Positiv
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
Pfizer Inc. (NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI (enzalutamide), …
Quelle: wallstreet-online.de
30. Mai 2026 16:00 Neutral
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in first-line metastatic colorectal cancer (mCRC) co-sponsored by Summit …
Quelle: wallstreet-online.de
30. Mai 2026 16:00 Positiv
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the introduction of Tempus Preview, an application providing rapid, clinically significant …
Quelle: wallstreet-online.de
30. Mai 2026 16:00 Positiv
Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage against active comparator in GIST patients; median PFS of 16.5 months versus 9.2 months (HR=0.50, CI: 0.39-0.65, p<0.0001) for …
Quelle: wallstreet-online.de
30. Mai 2026 16:00 Neutral
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved anti-tumor activity in platinum-resistant ovarian cancer and in uterine cancer with a 63% …
Quelle: wallstreet-online.de
30. Mai 2026 16:00 Neutral
Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company …
Quelle: wallstreet-online.de
30. Mai 2026 16:00 Neutral
Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
WOBURN, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented 3-year landmark overall survival …
Quelle: wallstreet-online.de
30. Mai 2026 16:00 Positiv
Otto-Versand: Otto hat viele Probleme ? aber auch eine Perle
Seit einem Jahr ist Petra Scharner-Wolff Chefin von Otto. Etwas profitabler hat sie den Konzern gemacht, doch der Schrumpfkurs hält an. Hier klicken, um den vollständigen Artikel zu lesen. [weiter]
Quelle: ariva.de
30. Mai 2026 15:56 Positiv
Von Iran beschlagnahmt: USA baut Krypto-Reserve um eine Milliarde US-Dollar aus
[weiter]
Quelle: ariva.de
30. Mai 2026 15:55 Positiv
Adidas – Comeback pünktlich zur WM
Adidas gehörte zuletzt zu den Werten, bei denen sich ein Stimmungswechsel auch im Kurs gezeigt hat. Mit dem Call-Optionsschein UQ9JE5 auf die Adidas-Aktie ergab sich in unserem Depot ein Plus …
Quelle: wallstreet-online.de
49.186 bis 49.200 von 54.205 Ergebnissen